Lygature was created in 2015 from the merger of the Center for Translational Molecular Medicine (CTMM) and Top-Institute Pharma (TI Pharma) to help preserve the expertise built up over many years, and to support new large Dutch or European initiatives. Lygature is a not-for-profit foundation has shown to be of added value in the European innovation ecosystem. We currently provide partnership management services to >20 projects where we work together with >100 partners. Our motto is: Pioneering Medicine. Together.
TI Pharma was launched in 2007 as the first life sciences ‘top institute’ in the Netherlands, (co-)funded from the proceeds of Dutch natural gas resources through the Fund for Economic Structure reinforcement (FES). It had a budget of EUR 274 million and focused on the development of new medicines. TI Pharma was soon followed by CTMM with a budget of EUR 300 million. CTMM was the first partnership to successfully integrate two converging fields of research: molecular diagnostics and imaging, with an initial focus on cardiovascular disease and oncology.